Scientists at the University of North Texas Health Science Center have released a study citing links between testosterone therapy and cognitive issues in Caucasian men. The study focused on the effect of testosterone-replacement therapy on men suffering from oxidative stress, a condition correlated with blood clots. According to the article, oxidative stress can in turn cause testosterone therapy to have additional side-effects.
The study indicates that in Caucasian males with elevated homocysteine levels, testosterone therapy may cause reduced cognition.
In conjunction with a significant increase in the number of testosterone prescriptions given out, there has been an increase in the observed side effects of testosterone therapy. Some of these side effects are believed to include heart attacks, strokes, deaths, and now, issues with cognition.
A consumer advocacy consortium, known as Public Citizen, has urged the FDA to add warning labels for these risks as they become more apparent and numerous. A group of physicians, called the Androgen Study Group, has recently responded to the claims against testosterone therapy, but their legitimacy as an objective voice independent of pharmaceutical companies is still in question. For example, the three of the five doctors listed as “members” of the study group have received approximately $80,000 between 2011 and 2012 from pharmaceutical manufacturers that market testosterone. Several are among the top prescribers of testosterone in the country, according to the non-profit organization, ProPublica.
After several studies demonstrated a likely link between testosterone therapy and heart attacks, strokes, blood clots and brain damage, injured men have begun to file lawsuits against the manufacturers of testosterone therapy products like Androgel and Testim. If you believe you have suffered harmful side effects from these or other prescription testosterone therapy products, contact the testosterone lawyers of Lopez McHugh to discuss a possible testosterone lawsuit.